<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Manufacturing Changes and Comparability for Human Cellular and Gene Therapy Products; Draft Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Manufacturing Changes and Comparability for Human Cellular and Gene Therapy Products; Draft Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2023-07-14 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a draft document entitled "Manufacturing Changes and Comparability for Human Cellular and Gene Therapy Products; Draft Guidance for Industry." The management of manufacturing changes presents many challenges for human cellular therapy or gene therapy (CGT) products due to the complexity of these products. The draft guidance provides sponsors of Investigational New Drug Applications (INDs) and applicants of Biologi...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2023-14917</p>
    <p><strong>Publication Date:</strong> 2023-07-14</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/07/14/2023-14917/manufacturing-changes-and-comparability-for-human-cellular-and-gene-therapy-products-draft-guidance">https://www.federalregister.gov/documents/2023/07/14/2023-14917/manufacturing-changes-and-comparability-for-human-cellular-and-gene-therapy-products-draft-guidance</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-14917</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
